Enveloped viral particles

Enveloped viral particles are a broad category of viruses characterized by an outer lipid bilayer membrane derived from the host cell during the budding process (NCBI, 2022). This envelope contains essential viral glycoproteins that facilitate host cell recognition, binding, and subsequent membrane fusion, which are critical steps for viral entry and infection (Nature Reviews Microbiology, 2019). Major human pathogens within this group include HIV-1, Influenza viruses, SARS-CoV-2, and Hepatitis B and C viruses. Because the lipid envelope is vital for the infectivity of these viruses, it is a primary target for various therapeutic strategies, including fusion inhibitors like enfuvirtide and neutralizing monoclonal antibodies like palivizumab (StatPearls, 2023). However, the term "Enveloped viral particles" is considered a broad classification of pathogens rather than a specific molecular target, as therapeutic agents usually interact with specific proteins or lipids within the envelope structure rather than the particle as a whole.

Other names

Enveloped virusesLipid-enveloped virusesViral envelopes

Drugs targeting enveloped viral particles typically function by inhibiting viral attachment to host cell receptors, blocking the fusion of the viral envelope with the host cell membrane, or disrupting the structural integrity of the lipid bilayer (NIH, 2023).